Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Fluid overload is common in chronic kidney disease (CKD) and may significantly impact patients’ perceived health status. We examined patient-reported outcome measures (PROMs) including health-related quality of life (HrQOL) among individuals who had chronic kidney disease and managed at a nurse-led clinic for patients with CKD and fluid overload.
Post-hoc analysis of a single-center prospective implementation study of adults in the Nurse-led Optimization of Volume and blood pressure – Enabling at multi-Levels using TechnologY (NOVELTY) program between August 2022 and April 2024. These patients had CKD not requiring dialysis and had fluid overload and/or systolic blood pressure (BP) >160 mmHg or diastolic BP >100 mmHg. HrQOL was assessed by the EuroQOL-5 Dimension [EQ5D5L] survey at the first visit and compared with patients’ sociodemographic and clinical characteristics including the 5-item SARC-F sarcopenia screen and PROM for chronic disease self-management (Partner in Health [PIH] questionnaire).
We included 65 participants who attended the first visit and completed the EQ5D5L survey. The median age was 67.4 (interquartile range [IQR]: 57.9, 76.5) years and the Charlson Comorbidity Index was 4 (IQR 3, 5). The median EQ5D5L score was 5 (IQR: 5, 7). The EQ5D5L score was significantly higher in older age (r = 0.35, p=0.004), female sex (median 6 [IQR: 5, 9] vs 5 [IQR: 5, 6] in male, p=0.02), not employed (median 6 [IQR: 5, 8] versus 5 [IQR: 5, 6] in employed), p=0.004), monthly income <$2000 (median 6 [IQR: 5, 8] versus 5 [IQR: 5, 5], p=0.01), higher CCI (r = 0.32, p=0.008), higher SARC-F score (r = 0.61, p<0.001), higher serum creatinine (r = 0.30, p=0.02), and two or more fluid overload-related symptoms in the past month (median 8 [IQR: 5, 11] versus 5 [IQR: 5, 6], p=0.02). EQ5D5L scores were lower with higher eGFR (r = -0.36, p=0.004) and RAS blocker treatment (median 5 [IQR: 5, 6] versus 6 [IQR: 5, 8] without treatment, p=0.046). The EQ5D5L score was not significantly associated with number of healthcare visits in the past 6 months, BP, weight, overhydration volume, or levels of serum calcium, phosphate, albumin, hemoglobin, HbA1c, lipids, NT-proBNP and UPCR in our cohort.
HrQOL is associated with clinical and socioeconomic determinants of health status among patients with CKD and fluid overload.
